Filed with the SEC on · accession 0001213900-26-116607
TARA filed a 8-K (current report) with the SEC on Nov 6, 2026. Protara Therapeutics furnished an 8-K announcing its financial results for the quarter ended September 30, 2026 via press release. The stock moved +1.4% by the first close after the filing.
Protara Therapeutics furnished an 8-K announcing its financial results for the quarter ended September 30, 2026 via press release. The filing is a routine quarterly earnings disclosure under Item 2.02.
Close before
$2.13
Nov 5, 2026
First close after
+1.41%
$2.16
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for TARA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TARA?
Click hereTARA filed a 8-K (SEC filing). Protara Therapeutics furnished an 8-K announcing its financial results for the quarter ended September 30, 2026 via press release. The filing is a routine quarterly earnings disclosure under Item 2.02.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
TARA closed at $2.13 before the filing and $2.16 on Nov 6, 2026 (+1.41%).
Get alerts when TARA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days